Poster Abstract Session:
154. Pharmacological Studies of Antifungals
Friday, October 9, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Tracks: Adult ID, Pediatric ID

In Vitro Activity of Manuka Honey and Polyhexamethylene Biguanide on Filamentous Fungi and Toxicity to Human Cells
Joseph Yabes Jr., MD ; Brian White, DO ; Katrin Mende, PhD ; Kevin S. Akers, MD, FIDSA ; Carlos Sanchez Jr., PhD ; Joseph Wenke, PhD ; Miriam Beckius, MPH ; Wendy Zera, BS ; Clinton K. Murray, MD, FIDSA
Genetic Polymorphisms and Its Relationship with the Concentration and Adverse Drug Reactions of Voriconazole in Taiwan
Yun-Ting He, M.S. ; Wei-Ting Chen, M.D. ; Yee-Chun Chen, MD, PhD ; Ching-Hua Kuo, Ph.D. ; Un-in Wu, M.D. ; Yu-Ting Huang, M.S. ; Yu-Ju Tseng, M.S. ; Li-Jiuan Shen, Ph.D. ; Shu-Wen Lin, PharmD, MS
Effectiveness for increasing administration frequency of posaconazole oral suspension to achieve therapeutic serum concentration in Korean patients with hematologic malignancy
Eun Jung Kim, MD ; Kyung-Sang Yu, PhD ; Kyoung-Ho Song, MD ; Pyeong-Gyun Choe, MD ; Ji Whan Bang, MD ; Eu Suk Kim, MD ; Sang-Won Park, MD, PhD ; Soo-Mee Bang, MD, PhD ; Hong Bin Kim, MD, PhD ; Inho Kim, MD, PhD ; Nam-Joong Kim, MD, PhD ; Wan Beom Park, MD, PhD ; Myoung-Don Oh, MD, PhD
In vitro Synergy of Tigecycline Plus Fluconazole Against Candida glabrata
Randol Hooper II, MS, MD ; Deborah S. Ashcraft, BS, MT ; George a. Pankey, MD, FIDSA
Therapeutic Dose Monitoring of Voriconazole in US Hospitals
Omneya Mohamed, PhD ; Anita Sung, PhD ; Stephen Marcella, M.D. ; Dongmu Zhang, Ph.D.
Evaluation of Prevalence of Potential Drug-Drug Interaction among Patients with Invasive Fungal Infections Receiving Mold-Active Triazoles
David Andes, MD, FIDSA ; Nkechi Azie, MD ; Hongbo Yang, PhD ; Caroline Kelley, BA ; Ruo-Ding Tan, Ph.D. ; Yichen Zhong, MHS ; Billy Franks, PhD ; Rita Kristy, MS ; Edward Lee, PharmD ; Nikhil Khandelwal, PhD ; James Spalding, PharmD

CME Credits:

ACPE Credits:

ACPE Number:

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.